30 Jan Kievit Scientific will support GN Corporation for the U.S. clinical study of autism

Dr. Samuel JK Abraham, MD, PhD has studied β-1, 3-1, 6- glucan produced by the Black Yeast AFO-202 strain and discovered that it enhances immunity in humans. He recently published a paper showing improvement of behavioral pattern in autism spectrum disorder with the beta-glucan supplement. Kievit Scientific will help Dr. Abraham to extend his clinical research in the U.S.